Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| IDEAYA Biosciences Inc | IDYA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 37.62 | 07:28:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 37.62 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 14.33 - 47.735 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 37.62 | USD |
IDEAYA Biosciences (IDYA) Options Flow Summary
IDEAYA Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.8B | 74.56M | - | 23.39M | -112.96M | -1.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
IDEAYA Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IDYA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 43.30 | 43.8353 | 37.51 | 39.94 | 497,446 | -5.68 | -13.12% |
| 1 Month | 45.32 | 45.32 | 37.51 | 41.96 | 551,945 | -7.70 | -16.99% |
| 3 Months | 42.71 | 47.735 | 37.51 | 44.08 | 702,800 | -5.09 | -11.92% |
| 6 Months | 26.59 | 47.735 | 23.41 | 37.26 | 905,181 | 11.03 | 41.48% |
| 1 Year | 14.76 | 47.735 | 14.33 | 31.43 | 778,925 | 22.86 | 154.88% |
| 3 Years | 20.53 | 47.735 | 8.14 | 24.42 | 494,752 | 17.09 | 83.24% |
| 5 Years | 14.00 | 47.735 | 2.95 | 22.84 | 353,675 | 23.62 | 168.71% |
IDEAYA Biosciences Description
| IDEAYA Biosciences Inc an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. |
